Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

Choose more journals

Article type Check one or more article types to show results from those article types only.
Subject Check one or more subjects to show results from those subjects only.
Date Choose a date option to show results from those dates only.

Custom date range

Clear all filters
Sort by:
Showing 1–2 of 2 results
Advanced filters: Author: "William Rosenberg" Clear advanced filters

  • 2010 was not a year of survival breakthroughs in hematologic malignancies. However, in Hodgkin's disease and multiple myeloma new therapies emerged as the standard of care and nilotinib may be considered the treatment choice for newly diagnosed chronic myeloid leukemia.

    • Vincent T. DeVita Jr
    • George P. Canellos
    News & Views
    Nature Reviews Clinical Oncology
    Volume: 8, P: 67-68

  • The advent of potent, pan-genotypic all-oral direct-acting antiviral (DAA) regimens necessitates a critical examination of the immediate application of PEG-IFN, ribavirin and DAA regimens in patients with chronic hepatitis C. This comprehensive Review outlines some of the conundrums facing physicians and summarizes current and pending treatment options for patients with hepatitis C.

    • Paul M. Trembling
    • Sudeep Tanwar
    • Geoffrey M. Dusheiko
    Reviews
    Nature Reviews Gastroenterology & Hepatology
    Volume: 10, P: 713-728